XIENCE™ Family of Drug-Eluting Stents

The World's Leading Drug-Eluting Stents (DES), with Unparalleled Clinical Outcomes¹

 XIENCE™ Family of Drug-Eluting Stents

XIENCE Sierra™ Stent

Even When Patients Are Complex—
Choosing a Stent Shouldn't Be

The design of XIENCE Sierra™ Stent is unlike that of other drug-eluting stents (DES). Its features combine a cobalt-chromium design with a fluoropolymer coating, to help:

  • Interventional cardiologists achieve enduring and positive patient outcomes1
  • Patients achieve a better quality of life2

The stent design ensures scaffold integrity and stent stability with significantly greater longitudinal strength than other DES.3
 

XIENCE Sierra™ Stent provides:

Learn More About XIENCE Sierra™ Stent

You can view clinical data about XIENCE Sierra™ Stent. You can also order XIENCE Sierra™ Stent to treat a broad spectrum of patients and lesions.

 Xience Sierra Stent
Explore Abbott's technologies for your needs.

Explore Abbott's technologies for your needs.

Access personalised education and training

Access personalised education and training

How can we help? Reach Abbott’s fast support here.

How can we help? Reach Abbott’s fast support here.

References

  1. Shiomi H, et al. JACC Cardiovasc Interv. 2019;12:637-647. Kufner S, et al. Circulation. 2019:139(3):325-333.
  2. Baron SJ, et al. J Am Coll Cardiol. 2017;70:3113-3122.
  3. Tests performed by and data on file at Abbott. XIENCE Sierra™ Stent – 3.0 x 28 mm, n=5; SYNERGY Stent – 3.0 x 28 mm, n=5; Resolute Onyx Stent –3.0 x 28 mm, n=5; Orsiro Stent System – 3.0 x 28 mm, n=5.
  4. Tests performed by and data on file at Abbott. XIENCE Sierra™ Stent – 3.0 x 18 mm, n=5; SYNERGY Stent – 3.0 x 20 mm, n=5; Resolute Onyx Stent –3.0 x 18 mm.
  5. XIENCE Sierra™ Stent IFU. XIENCE Alpine™ Stent IFU.
  6. Zanchin C, et al. JACC Cardiovasc Interv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Shiomi H, et al. JACC Cardiovasc Interv. 2019;12:637-647. Kufner S, et al. Circulation. 2019:139(3):325-333. Palmerini T, et al. Lancet. 2013;379:1393-1402. Bangalore S, et al. Circulation. 2012;125:2873-2891. Bangalore S, et al. Circ Cardiovasc Interv. 2013;6(6):378-390. Pilgrim T, et al. Lancet. 2014;384:2111-2122. Pilgrim T, et al. Lancet. 2018;392:737-746. Data on File at Abbott.

MAT-2413506 V1.0